J.Jill lowers outlook as Q2 profits, sales slide

US clothing retailer J.Jill has booked lower net profit for the second quarter (Q2) as sales slowed during the start of the period.

Discovery and Preclinical Pharmacology of NX-2127, an Orally Bioavailable Degrader of Bruton's Tyrosine Kinase with Immunomodulatory Activity for the Treatment of Patients with B Cell Malignancies

Inside The New York Times' Big Bet on Games

TJX Companies posts 2 percent sales drop in Q2 but lifts FY23 outlook

Separations Announcements

Týdenní přehled J&T Banky (16. - 20. května 2011)

LC 02 2024 by Larchmont Chronicle - Issuu

J.Jill Sees Q2 Dips in Sales and Income

J.Jill Sees Q2 Dips in Sales and Income

Dual-Monitor Arm 180 Degree, Small Monitor Stands

J.Jill: Improved Profitability With Fewer Stores (NYSE:JILL)

Casey's General Stores Inc Reports Mixed Q3 Results Amidst Expansion and Margin Improvements

Advancing Computational Toxicology by Interpretable Machine Learning

Quo Vadis, Trinote Planner

JLL Reports Financial Results for Fourth-Quarter and Full-Year 2023

J.Jill: Improved Profitability With Fewer Stores (NYSE:JILL)